Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $17.00.
Several analysts have recently weighed in on SENS shares. Stifel Nicolaus reduced their price objective on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Monday, May 11th. Weiss Ratings downgraded shares of Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 28th. Finally, HC Wainwright reduced their price target on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th.
Read Our Latest Report on Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc. Common Stock Trading Down 5.4%
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.71) earnings per share for the quarter, missing the consensus estimate of ($0.65) by ($0.06). The company had revenue of $11.71 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 129.97% and a negative net margin of 213.87%. As a group, equities research analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.38 EPS for the current fiscal year.
Insider Buying and Selling
In other Senseonics Holdings, Inc. Common Stock news, Director Douglas A. Roeder purchased 22,686 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Tuesday, May 12th. The stock was purchased at an average price of $5.56 per share, for a total transaction of $126,134.16. Following the transaction, the director directly owned 144,635 shares in the company, valued at $804,170.60. This trade represents a 18.60% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 4.70% of the stock is currently owned by company insiders.
Institutional Trading of Senseonics Holdings, Inc. Common Stock
Several institutional investors and hedge funds have recently bought and sold shares of the business. First Light Asset Management LLC raised its position in Senseonics Holdings, Inc. Common Stock by 666.7% in the 2nd quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock valued at $17,011,000 after purchasing an additional 31,050,619 shares during the last quarter. Vanguard Group Inc. raised its position in Senseonics Holdings, Inc. Common Stock by 2.2% in the 3rd quarter. Vanguard Group Inc. now owns 34,219,484 shares of the company’s stock valued at $14,920,000 after purchasing an additional 749,453 shares during the last quarter. Geode Capital Management LLC raised its position in Senseonics Holdings, Inc. Common Stock by 26.6% during the 2nd quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock worth $4,147,000 after buying an additional 1,828,302 shares during the last quarter. Masters Capital Management LLC raised its position in Senseonics Holdings, Inc. Common Stock by 11.1% during the 3rd quarter. Masters Capital Management LLC now owns 5,000,000 shares of the company’s stock worth $2,179,000 after buying an additional 500,000 shares during the last quarter. Finally, UBS Group AG raised its position in Senseonics Holdings, Inc. Common Stock by 409.0% during the 3rd quarter. UBS Group AG now owns 4,248,519 shares of the company’s stock worth $1,852,000 after buying an additional 3,413,866 shares during the last quarter. Hedge funds and other institutional investors own 12.36% of the company’s stock.
Senseonics Holdings, Inc. Common Stock Company Profile
Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.
Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.
Read More
- Five stocks we like better than Senseonics Holdings, Inc. Common Stock
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
